CTD // Fund

Ncore Ventures

Seoul-based venture capital firm

Ncore Ventures

South Korea

Ncore Ventures is an institutional investor (Conventional VCs) founded in 2017 and headquartered in Seoul, South Korea. NCORE VENTURES is a Seoul-based Venture capital firm that invests in early-stage startups. Portfolio of investments include Amyloid solution, true balance, buzzusiq and 500. Notable portfolio companies: Amyloid solution, true balance, buzzusiq and 500.

Stage: early-stage, Series A, Series B, Series C, mid to late-stage, early-stage, Series A, Series B, Series C, mid to late-stage
Check size: $10M-$30M
HQ: Seoul, South Korea
Founded: 2017
Website: http://ncorevc.com
LinkedIn: https://linkedin.com/company/ncore-ventures

Institutional InvestorConsumerEnterpriseBio & Healthcaretechnologyhealthcare

What they look for

Innovative, persistent entrepreneurs challenging status quo; U.S. and Asia (Korea, Southeast Asia); startups ~4-5+ years old

Related startups

Cogent

Cogent Labs is a Tokyo-based AI company that develops artificial intelligence solutions for data extraction and document processing.

High Tech · Shibuya, Japan

Rebus Biosystems

Rebus Biosystems develops an imaging system for analyzing genes in single cells using its patented Synthetic Aperture Optics system for multiple gene…

Life Sciences · Santa Clara, United States

Wellysis

Wellysis develops a smart wearable wristband and companion application for continuous ECG monitoring, enabling users to verify live-streaming…

HealthTech · Seoul, South Korea

📊 Ballpark pre-money for pipeline deals — estimate equity value before you diligence a round.

⚠️ Common pitch mistakes we see →

Preparing to pitch Ncore Ventures?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →